Immunotherapy plus chemo approved after surgery for some colon cancers
Published
Tecentriq is now approved with chemo for stage III colon cancer with a specific genetic feature (dMMR). Adding it cut the risk of the cancer returning by about half in a trial.
Source: FDA
This is a plain-language summary. Read the original source for full details.